CRSP
Price
$53.51
Change
-$0.70 (-1.29%)
Updated
Jan 16 closing price
Capitalization
5.1B
30 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.76
Change
-$0.06 (-1.57%)
Updated
Jan 16 closing price
Capitalization
209.06M
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRSP vs VYGR

Header iconCRSP vs VYGR Comparison
Open Charts CRSP vs VYGRBanner chart's image
CRISPR Therapeutics AG
Price$53.51
Change-$0.70 (-1.29%)
Volume$1.41M
Capitalization5.1B
Voyager Therapeutics
Price$3.76
Change-$0.06 (-1.57%)
Volume$569.62K
Capitalization209.06M
CRSP vs VYGR Comparison Chart in %
View a ticker or compare two or three
VS
CRSP vs. VYGR commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (CRSP: $53.51 vs. VYGR: $3.76)
Brand notoriety: CRSP and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 72% vs. VYGR: 117%
Market capitalization -- CRSP: $5.1B vs. VYGR: $209.06M
CRSP [@Biotechnology] is valued at $5.1B. VYGR’s [@Biotechnology] market capitalization is $209.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than VYGR.

Price Growth

CRSP (@Biotechnology) experienced а -0.61% price change this week, while VYGR (@Biotechnology) price change was -6.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 17, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.1B) has a higher market cap than VYGR($209M). CRSP YTD gains are higher at: 2.040 vs. VYGR (-4.326). VYGR has higher annual earnings (EBITDA): -136.19M vs. CRSP (-555.73M). CRSP has more cash in the bank: 1.92B vs. VYGR (45.1M). VYGR has less debt than CRSP: VYGR (38.4M) vs CRSP (211M). CRSP has higher revenues than VYGR: CRSP (35M) vs VYGR (31.3M).
CRSPVYGRCRSP / VYGR
Capitalization5.1B209M2,440%
EBITDA-555.73M-136.19M408%
Gain YTD2.040-4.326-47%
P/E RatioN/A6.00-
Revenue35M31.3M112%
Total Cash1.92B45.1M4,248%
Total Debt211M38.4M549%
FUNDAMENTALS RATINGS
CRSP vs VYGR: Fundamental Ratings
CRSP
VYGR
OUTLOOK RATING
1..100
1868
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
789
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (47) in the Biotechnology industry is in the same range as CRSP (72). This means that VYGR’s stock grew similarly to CRSP’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRSP (100). This means that VYGR’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (96) in the Biotechnology industry is in the same range as VYGR (97). This means that CRSP’s stock grew similarly to VYGR’s over the last 12 months.

CRSP's Price Growth Rating (62) in the Biotechnology industry is in the same range as VYGR (64). This means that CRSP’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for CRSP (78). This means that VYGR’s stock grew significantly faster than CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPVYGR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRGEX35.990.33
+0.93%
Virtus Duff & Phelps Glb Rl Estt Secs R6
RNWAX92.39-0.03
-0.03%
American Funds New World R1
HILVX20.56-0.01
-0.05%
Harbor Large Cap Value Inv
BARAX88.83-0.06
-0.07%
Baron Asset Retail
COPLX209.82-0.62
-0.29%
Copley Fund

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.29%
BEAM - CRSP
72%
Closely correlated
-2.59%
RXRX - CRSP
68%
Closely correlated
+0.65%
ABSI - CRSP
62%
Loosely correlated
-0.98%
PRME - CRSP
60%
Loosely correlated
-0.25%
NTLA - CRSP
59%
Loosely correlated
+5.31%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with KURA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-1.57%
KURA - VYGR
55%
Loosely correlated
-5.05%
RGNX - VYGR
55%
Loosely correlated
-1.02%
XNCR - VYGR
54%
Loosely correlated
-3.18%
IMNM - VYGR
50%
Loosely correlated
-1.93%
CRSP - VYGR
49%
Loosely correlated
-1.29%
More